Flynn Zito Capital Management, LLC Bristol Myers Squibb CO Transaction History

Flynn Zito Capital Management, LLC

  • $205 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022
BUY
$0.13 - $76.84 $374 - $221,376
2,881 New
2,881 $205,000
Q2 2022

Jul 28, 2022
SELL
$72.62 - $79.98 $241,897 - $266,413
-3,331 Closed
0 $0
Q1 2022

May 05, 2022
SELL
$61.48 - $73.72 $24,592 - $29,488
-400 Reduced 10.72%
3,331 $243,000
Q4 2021

Feb 10, 2022
BUY
$53.63 - $62.52 $200,093 - $233,262
3,731 New
3,731 $233,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Flynn Zito Capital Management, LLC Portfolio

Follow Flynn Zito Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flynn Zito Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flynn Zito Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email